BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15243631)

  • 1. Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector.
    Hoggarth JH; Jones E; Ensser A; Meredith DM
    Cancer Gene Ther; 2004 Sep; 11(9):613-24. PubMed ID: 15243631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy.
    Steffens S; Frank S; Fischer U; Heuser C; Meyer KL; Dobberstein KU; Rainov NG; Kramm CM
    Cancer Gene Ther; 2000 May; 7(5):806-12. PubMed ID: 10830728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
    Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
    Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
    Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ
    J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir.
    Rivas C; Miller AR; Collado M; Lam EW; Apperley JF; Melo JV
    Mol Ther; 2001 May; 3(5 Pt 1):642-52. PubMed ID: 11356068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
    Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
    Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
    Degrève B; De Clercq E; Balzarini J
    Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.
    Candotti F; Agbaria R; Mullen CA; Touraine R; Balzarini J; Johns DG; Blaese RM
    Cancer Gene Ther; 2000 Apr; 7(4):574-80. PubMed ID: 10811475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J; Ma L; Wei L
    Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A herpesvirus saimiri-based gene therapy vector with potential for use in cancer immunotherapy.
    Stevenson AJ; Frolova-Jones E; Hall KT; Kinsey SE; Markham AF; Whitehouse A; Meredith DM
    Cancer Gene Ther; 2000 Jul; 7(7):1077-85. PubMed ID: 10917211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesvirus saimiri pathogenicity enhanced by thymidine kinase of herpes simplex virus.
    Hiller C; Tamgüney G; Stolte N; Mätz-Rensing K; Lorenzen D; Hör S; Thurau M; Wittmann S; Slavin S; Fickenscher H
    Virology; 2000 Dec; 278(2):445-55. PubMed ID: 11118367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Killing effect of adenovirus vector-mediated herpes simplex virus thymidine kinase gene recombinant construct on various cancer cells].
    Zhou JF; Chen G; Lu YP; Wang SX; Ma D
    Ai Zheng; 2003 Dec; 22(12):1264-7. PubMed ID: 14693048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
    Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-proliferative effect of herpes simplex virus thymidine kinase gene system on human Tenon capsule fibroblasts in vitro].
    Wang JB; Ge J; Liu BQ; Huang B; Wei YT
    Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):212-7. PubMed ID: 16643751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
    Yang J; Liu TJ; Lu Y
    Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
    Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
    J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.